Cancer Drug's Real-World performance under watch in korea
NCT ID NCT04982848
Summary
This study will monitor how well Talzenna works and what side effects occur when used in real-world clinical practice for advanced breast cancer with BRCA gene mutations. It will observe 600 Korean patients who are already prescribed Talzenna by their doctors. The goal is to gather safety and effectiveness data after the drug becomes available in Korea.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.